Readmissions following major oncologic operation are common—affecting patient treatment, outcome, and hospital resources. The Center for Medicare and Medicaid Services mandates reporting of certain disease-specific readmissions and Congress is considering…
Surgical mortality with oncologic surgery varies widely in the United States. Patients, providers, and payers are paying closer attention to these variations and a way of reducing them. Although different…
The primary objective of the Commission on Cancer (CoC) is to ensure the delivery of comprehensive, high-quality care that improves survival while maintaining quality of life for patients with cancer….
For most cancers, surgical therapy offers the only hope for cure. Nevertheless, evidence suggests wide variation in cancer care, and therefore it is imperative to ensure that high standards of…
Clifford Y. Ko, MD, MS, MSHS, Guest Editor Approximately 1.5 million new cancers are diagnosed every year in the United States. Despite improvements in medical therapy, surgical resection remains the…
Upwards of 40% of patient with colorectal cancer develop peritoneal carcinomatosis (CRCPC). Of the 2500 patients reported in the literature, 1000 underwent cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC),…
Epithelial ovarian cancer is a peritoneal surface malignancy that most often presents with spread of disease within the peritoneal cavity. Overall 5-year survival is around 50% and progress in improving…
The benefits that are reported in patients who have carcinomatosis from colorectal cancer increase as the extent of disease within the abdomen and pelvis decreases. To optimize treatments that involve…
Peritoneal mesothelioma is a rare malignancy where life expectancy with systemic chemotherapy remains poor. Most patients with this disease are diagnosed late with extensive peritoneal disease burden leading to nausea,…
Peritoneal carcinomatosis arising from gastric cancer is mostly associated with poor prognosis. Despite the improvement of survival with modern polychemotherapy, the results are still unsatisfactory. Cytoreductive surgery and hyperthermic intraperitoneal…
